PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
18-Feb-2020 Aridis Pharmaceuticals to Host Investor Day Showcasing APEX(TM) Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia Aridis Pharmaceuticals, Inc.
17-Feb-2020 PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results PTC Therapeutics, Inc.
17-Feb-2020 Director resignation NMC Health plc
17-Feb-2020 Castor provides free access to data capture platform to support non-profit COVID19 research projects Castor
17-Feb-2020 ReNeuron Group plc - Positive Phase 2a stroke clinical data published ReNeuron Group plc
17-Feb-2020 Vifor Pharma acquires Priority Review Voucher Vifor Pharma Group
17-Feb-2020 Analysis of RNA sequences and modifications by mass spectrometry published in Nature Communications STORM Therapeutics Ltd
17-Feb-2020 Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn’s Disease Takeda Pharmaceutical Company Limited
17-Feb-2020 OMass Therapeutics Announces £27.5 Million Extended Series A Financing OMass Therapeutics
17-Feb-2020 Arctoris announces partnership with Molecule to tackle the innovation crisis in drug discovery and development Arctoris
17-Feb-2020 Thermo Fisher Scientific's Advanced Analytical Instruments Recognized Through Respected Industry Awards Thermo Fisher Scientific
15-Feb-2020 Adverum (ADVM) Alert: Johnson Fistel Launches Investigation into Adverum Biotechnologies; Investors Encouraged to Contact Firm Johnson Fistel, LLP
14-Feb-2020 Regeneron’s therapeutic candidate for rare cholesterol disease expected to face pricing pressure, says GlobalData GlobalData
14-Feb-2020 Corrected Press Release: XBiotech Announces Preliminary Results of Tender Offer XBiotech
14-Feb-2020 New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) Janssen Pharmaceutical Companies of Johnson & Johnson
14-Feb-2020 Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research Verona Pharma
14-Feb-2020 New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas Helsinn Group
14-Feb-2020 GeneTx Announces IRB Approval to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome GeneTx
14-Feb-2020 CTI BioPharma Announces Commencement of Rights Offering CTI BioPharma Corp.
14-Feb-2020 CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement CollPlant